Ischemic Heart Disease Rising in Young Women 10/08/25
Welcome to Cardiology Today â Recorded October 08, 2025. This episode summarizes 5 key cardiology studies on topics like undiagnosed heart failure and fractional flow reserve. Key takeaway: Ischemic Heart Disease Rising in Young Women.
Article Links:
Article 1: Fractional flow reserve-guided renal artery stenting in atherosclerotic renovascular hypertension: the FAIR randomized trial. (European heart journal)
Article 2: Genetic variants of glucose-dependent insulinotropic polypeptide (GIP) signalling as proxy for body weight reduction and cardiovascular risk. (European heart journal)
Article 3: Stable angina in young women. (European heart journal)
Article 4: Characterisation and prognostic implications of the 12-lead electrocardiogram in children with RASopathy-associated hypertrophic cardiomyopathy. (Heart (British Cardiac Society))
Article 5: Assessing cardiovascular benefits of intensive blood pressure lowering in high-risk undiagnosed HFpEF patients. (ESC heart failure)
Full episode page: https://podcast.explainheart.com/podcast/ischemic-heart-disease-rising-in-young-women-10-08-25/
đ Featured Articles
Article 1: Fractional flow reserve-guided renal artery stenting in atherosclerotic renovascular hypertension: the FAIR randomized trial.
Journal: European heart journal
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41056188
Summary: The FAIR randomized trial aims to compare Fractional Flow Reserve (F.F.R.)-guided renal artery revascularization with traditional angiography-guided revascularization for atherosclerotic renovascular hypertension. This ongoing study enrolled 101 patients with atherosclerotic renal artery stenosis (A.R.A.S.) and hypertension, randomizing them to F.F.R.-guided or angiography-guided groups. In the angiography group, stenting was performed irrespective of F.F.R. values, but specific outcomes or findings are not yet reported.
Article 2: Genetic variants of glucose-dependent insulinotropic polypeptide (GIP) signalling as proxy for body weight reduction and cardiovascular risk.
Journal: European heart journal
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41056187
Summary: This study investigates whether genetically proxied body weight reduction through the Glucose-Dependent Insulinotropic Polypeptide (G.I.P.) receptor pathway can lower cardiovascular disease risk. It also aims to compare this effect with polygenic weight reduction pathways. The abstract describes the study’s objectives and methodology, but it does not present specific findings or conclusions regarding cardiovascular outcomes.
Article 3: Stable angina in young women.
Journal: European heart journal
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41055899
Summary: Ischemic Heart Disease (I.H.D.) prevalence is concerningly rising in younger women, with a 3 percent increase between 1990 and 2019, and I.H.D. mortality in this demographic is increasing in some high-income countries. Angina serves as the primary presenting symptom for suspected I.H.D. and coronary artery disease. This article highlights critical epidemiological trends emphasizing the increasing burden of Ischemic Heart Disease in young women globally, warranting heightened clinical attention.
Article 4: Characterisation and prognostic implications of the 12-lead electrocardiogram in children with RASopathy-associated hypertrophic cardiomyopathy.
Journal: Heart (British Cardiac Society)
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41057251
Summary: This retrospective cohort study aimed to characterize twelve-lead Electrocardiogram (E.C.G.) findings and identify potential E.C.G. predictors of Major Adverse Cardiovascular Events (M.A.C.E.) in children with RASopathy-associated hypertrophic cardiomyopathy (H.C.M.). Major Adverse Cardiovascular Events included cardiovascular mortality, resuscitated cardiac arrest, ventricular arrhythmias, appropriate implantable cardioverter defibrillator therapy, or heart failure. While the study design and its objectives are detailed, the abstract does not report specific E.C.G. characteristics or identified prognostic implications.
Article 5: Assessing cardiovascular benefits of intensive blood pressure lowering in high-risk undiagnosed HFpEF patients.
Journal: ESC heart failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41055670
Summary: A post-hoc analysis of the Systolic Blood Pressure Intervention Trial (S.P.R.I.N.T.) evaluated the Heart Failure with Preserved Ejection Fraction (H.F.pEF)-A.B.A. score’s utility in identifying high-risk, undiagnosed H.F.pEF subgroups with elevated cardiovascular event rates. The H.F.pEF-A.B.A. score successfully identified these high-risk individuals with undiagnosed H.F.pEF. While the analysis aimed to assess intensive blood pressure control’s impact, specific cardiovascular benefits or outcomes related to this intervention are not detailed in the abstract.
đ Transcript
Today’s date is October 08, 2025. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Fractional flow reserve-guided renal artery stenting in atherosclerotic renovascular hypertension: the FAIR randomized trial. The FAIR randomized trial aims to compare Fractional Flow Reserve (F.F.R.)-guided renal artery revascularization with traditional angiography-guided revascularization for atherosclerotic renovascular hypertension. This ongoing study enrolled 101 patients with atherosclerotic renal artery stenosis (A.R.A.S.) and hypertension, randomizing them to F.F.R.-guided or angiography-guided groups. In the angiography group, stenting was performed irrespective of F.F.R. values, but specific outcomes or findings are not yet reported.
Article number two. Genetic variants of glucose-dependent insulinotropic polypeptide (G.I.P.) signalling as proxy for body weight reduction and cardiovascular risk. This study investigates whether genetically proxied body weight reduction through the Glucose-Dependent Insulinotropic Polypeptide (G.I.P.) receptor pathway can lower cardiovascular disease risk. It also aims to compare this effect with polygenic weight reduction pathways. The abstract describes the study’s objectives and methodology, but it does not present specific findings or conclusions regarding cardiovascular outcomes.
Article number three. Stable angina in young women. Ischemic Heart Disease (I.H.D.) prevalence is concerningly rising in younger women, with a 3 percent increase between 1990 and 2019, and I.H.D. mortality in this demographic is increasing in some high-income countries. Angina serves as the primary presenting symptom for suspected I.H.D. and coronary artery disease. This article highlights critical epidemiological trends emphasizing the increasing burden of Ischemic Heart Disease in young women globally, warranting heightened clinical attention.
Article number four. Characterisation and prognostic implications of the 12-lead electrocardiogram in children with RASopathy-associated hypertrophic cardiomyopathy. This retrospective cohort study aimed to characterize twelve-lead Electrocardiogram (E.C.G.) findings and identify potential E.C.G. predictors of Major Adverse Cardiovascular Events (M.A.C.E.) in children with RASopathy-associated hypertrophic cardiomyopathy (H.C.M.). Major Adverse Cardiovascular Events included cardiovascular mortality, resuscitated cardiac arrest, ventricular arrhythmias, appropriate implantable cardioverter defibrillator therapy, or heart failure. While the study design and its objectives are detailed, the abstract does not report specific E.C.G. characteristics or identified prognostic implications.
Article number five. Assessing cardiovascular benefits of intensive blood pressure lowering in high-risk undiagnosed H.F.pEF patients. A post-hoc analysis of the Systolic Blood Pressure Intervention Trial (S.P.R.I.N.T.) evaluated the Heart Failure with Preserved Ejection Fraction (H.F.pEF)-A.B.A. score’s utility in identifying high-risk, undiagnosed H.F.pEF subgroups with elevated cardiovascular event rates. The H.F.pEF-A.B.A. score successfully identified these high-risk individuals with undiagnosed H.F.pEF. While the analysis aimed to assess intensive blood pressure control’s impact, specific cardiovascular benefits or outcomes related to this intervention are not detailed in the abstract.
Thank you for listening. Don’t forget to subscribe.
đ Keywords
undiagnosed heart failure, fractional flow reserve, genetic variants, pediatric cardiology, revascularization, Ischemic heart disease, epidemiology, body weight reduction, intensive blood pressure control, young women, G.I.P. receptor, stable angina, renal artery stenting, RASopathy, Renal artery stenosis, electrocardiogram, Hypertrophic cardiomyopathy, H.F.pEF-A.B.A. score, S.P.R.I.N.T. trial, Glucose-dependent insulinotropic polypeptide, major adverse cardiovascular events, atherosclerotic renovascular hypertension, Heart failure with preserved ejection fraction, cardiovascular mortality, cardiovascular risk.
âšī¸ About
Concise summaries of cardiovascular research for professionals.
Subscribe âĸ Share âĸ Follow